KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Sub-cellular biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-030-94004-1_10PMID 35378709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance.

  2020cited by this paper
• Macropinocytosis Renders a Subset of Pancreatic Tumor Cells Resistant to mTOR Inhibition

  2020cited by this paper
• Rac-Mediated Macropinocytosis of Extracellular Protein Promotes Glucose Independence in Non-Small Cell Lung Cancer

  2019cited by this paper
• Integrin trafficking in cells and tissues

  2019cited by this paper
• Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models.

  2019cited by this paper
• Targeting the untargetable KRAS in cancer therapy

  2019cited by this paper
• Syndecan1 is a critical mediator of macropinocytosis in pancreatic cancer

  2019cited by this paper
• Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.

  2019cited by this paper
• A Comparative Analysis of Individual RAS Mutations in Cancer Biology

  2019cited by this paper
• Galectin-3 Coordinates a Cellular System for Lysosomal Repair and Removal.

  2019cited by this paper
• Extracellular and macropinocytosis internalized ATP work together to induce epithelial–mesenchymal transition and other early metastatic activities in lung cancer

  2019cited by this paper
• The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?†

  2019cited by this paper
• EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis.

  2019cited by this paper
• KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.

  2018cited by this paper
• Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

  2018cited by this paper
• Differential Effector Engagement by Oncogenic KRAS.

  2018cited by this paper
• Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers.

  2018cited by this paper
• Macropinocytosis and autophagy crosstalk in nutrient scavenging

  2018cited by this paper
• Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins

  2018cited by this paper
• Critical role for PI3-kinase in regulating the use of proteins as an amino acid source

  2017cited by this paper
• Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer

  2017cited by this paper
• Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers.

  2017cited by this paper
• Drugging RAS: Know the enemy

  2017cited by this paper
• Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

  2017cited by this paper
• Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.

  2017cited by this paper
• Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK

  2017cited by this paper
• Starved epithelial cells uptake extracellular matrix for survival

  2017cited by this paper
• Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase

  2017cited by this paper
• XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

  2016cited by this paper
• Regulation of K-Ras4B Membrane Binding by Calmodulin.

  2016cited by this paper
• Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery

  2016cited by this paper
• Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors

  2016cited by this paper
• Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers

  2016cited by this paper
• Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

  2015cited by this paper
• K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.

  2015cited by this paper
• Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

  2015cited by this paper
• Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

  2015cited by this paper
• GTP-Dependent K-Ras Dimerization.

  2015cited by this paper
• The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.

  2015cited by this paper
• Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions.

  2015cited by this paper
• Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies

  2014cited by this paper
• Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.

  2014cited by this paper
• KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport.

  2014cited by this paper
• KRAS: feeding pancreatic cancer proliferation.

  2014cited by this paper
• Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers

  2014cited by this paper
• An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition

  2014cited by this paper
• Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

  2013cited by this paper
• Syndecan-4 Phosphorylation Is a Control Point for Integrin Recycling

  2013cited by this paper
• Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling

  2013cited by this paper
• The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.

  2012cited by this paper
• Syndecan-4 independently regulates multiple small GTPases to promote fibroblast migration during wound healing

  2012cited by this paper
• Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration

  2011cited by this paper
• CD81 is essential for the formation of membrane protrusions and regulates Rac1-activation in adhesion-dependent immune cell migration.

  2011cited by this paper
• Tumor angiogenesis: molecular pathways and therapeutic targets

  2011cited by this paper
• RAS oncogenes: weaving a tumorigenic web

  2011cited by this paper
• Nucleophosmin and nucleolin regulate K-Ras signaling

  2010cited by this paper
• Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

  2009cited by this paper
• Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.

  2009cited by this paper
• Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.

  2009cited by this paper
• A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

  2009cited by this paper
• Hypoxia, HIF1 and glucose metabolism in the solid tumour

  2008cited by this paper
• K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.

  2008cited by this paper
• GEFs and GAPs: critical elements in the control of small G proteins.

  2007cited by this paper
• Synergistic control of cell adhesion by integrins and syndecans

  2007cited by this paper
• The role of AMPK and mTOR in nutrient sensing in pancreatic beta-cells.

  2007cited by this paper
• Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression.

  2005cited by this paper
• H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton

  2005cited by this paper
• Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells.

  2005cited by this paper
• Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.

  2005cited by this paper
• Ras proteins: different signals from different locations

  2003cited by this paper
• Direct visualization of Ras proteins in spatially distinct cell surface microdomains

  2003cited by this paper
• Targeting RAS signalling pathways in cancer therapy

  2003cited by this paper
• Stable suppression of tumorigenicity by virus-mediated RNA interference.

  2002cited by this paper
• Role of integrins in cell invasion and migration

  2002cited by this paper
• PKC epsilon controls the traffic of beta1 integrins in motile cells.

  2002cited by this paper
• Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement.

  2001cited by this paper
• Complexes of tetraspanins with integrins: more than meets the eye.

  2001cited by this paper
• Transmembrane-4 Superfamily Proteins Associate with Activated Protein Kinase C (PKC) and Link PKC to Specific β1 Integrins*

  2001cited by this paper
• Tetraspanins

  2001cited by this paper
• Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions.

  1999cited by this paper
• Polylysine domain of K-ras 4B protein is crucial for malignant transformation.

  1994cited by this paper
• Phosphatidylinositol-3-OH kinase direct target of Ras

  1994cited by this paper
• A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane.

  1990cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• The p21 ras C-terminus is required for transformation and membrane association

  1984cited by this paper

• Revolutionizing Cancer Care: The Role of 3D Printing in Personalized Oncology

  2025cites this paper
• The current understanding of KRAS oligomerization on membranes.

  2025cites this paper
• Targeting mTOR Signaling by Dietary Polysaccharides in Cancer Prevention: Advances and Challenges.

  2022cites this paper